A recent study speculated that HERC2-mediated p53 ubiquitination and degradation was inhibited by BTF3, which functions as an oncogene in CRC (Table 1) [69], but functional analysis of HERC2 and p53 with BTF3 needs subsequent study. This evidence concerns the gene TP53 and colorectal carcinoma.